A casecontrol study of risk factors for urinary acquisition of Klebsiella pneumoniae producing CTX-M-15 in an outbreak situation in Sweden

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 6-7, 2010, Pages 439-444

  Lytsy, Birgitta ^a   Lindbck, Johan ^a   Torell, Erik ^b   Sylvan, Staffan ^c   Velicko, Inga ^d   Melhus, Åsa ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b GÄVLE HOSPITAL   (Sweden)

^c Smittskyddsenheten   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; IMIDAZOLE DERIVATIVE; MACROLIDE; MECILLINAM; MONOBACTAM DERIVATIVE; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; BETA LACTAMASE; BETA LACTAMASE CTX M 15; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CASE CONTROL STUDY; CONTROLLED STUDY; DIARRHEA; DRUG USE; EPIDEMIC; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MICROBIOLOGICAL EXAMINATION; NASOGASTRIC TUBE; NONHUMAN; RETROSPECTIVE STUDY; RISK FACTOR; SWEDEN; URINARY TRACT INFECTION; URINE CULTURE; AGED; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; RISK; STATISTICAL MODEL; URINE;

AGED; AGED, 80 AND OVER; BETA-LACTAMASES; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; URINE;

EID: 77953265928     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903582434     Document Type: Article

References (25)

1. Jarvis WR, Munn VP, Highsmith AK, Culver DH, Hughes JM. The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infection Control 1985;6:68-74.
2. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603.
3. Montgomerie JZ. Epidemiology of Klebsiella and hospitalassociated infections. Rev Infect Dis 1979;1:736-753
4. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007;60:913-920
5. Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic R. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813-821
6. Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2006;193:645-654
7. Balestrino D, Ghigo JM, Charbonnel N, Haagensen JA, Forestier C. The characterization of functions involved in the establishment and maturation of Klebsiella pneumoniae in vitro biofi lm reveals dual roles for surface exopolysaccharides. Environ Microbiol 2008;10:685-701.
8. Yang D, Zhang Z. Biofi lm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. J Hosp Infect 2008;68:369-371
9. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004; 39:31-37
10. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686
11. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-475
12. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171
13. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extendedspectrum beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006;50:498-504.
14. Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N. Epidemiology of infections caused by extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London. J Hosp Infect 2006;64:115-123
15. Kanafani ZA, Mehio-Sibai A, Araj GF, Kanaan M, Kanj SS. Epidemiology and risk factors for extended-spectrum betalactamase- producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 2005; 33:326-332
16. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The fi rst major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M- 15. APMIS 2008;116:302-308
17. Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002;23: 254-260
18. Lima NL, Guerrant RL, Kaiser DL, Germanson T, Farr BM. A retrospective cohort study of nosocomial diarrhea as a risk factor for nosocomial infection. J Infect Dis 1990;161: 948-952
19. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epide miology of community-onset, extended-spectrum beta-lactamaseproducing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control 2007;35: 606-612
20. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003;53:39-45.
21. Graffunder EM, Preston KE, Evans AM, Venezia RA. Risk factors associated with extended-spectrum beta-lactamaseproducing organisms at a tertiary care hospital. J Antimicrob Chemother 2005;56:139-145
22. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Cueto M, Galvez J, et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum betalactamase- producing Escherichia coli. Clin Microbiol Infect 2008;14:180-183
23. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 2002;34:1558-1563
24. Falagas ME, Mourtzoukou EG, Ntziora F, Peppas G, Rafailidis PI. Matching criteria in case-control studies on postoperative infections. J Hosp Infect 2008;69:101-113
25. Behar PR, Teixeira PJ, Fachel JM, Kalil AC. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study. J Hosp Infect 2008;68:123-129